Recruiting
Gastrointestinal cancer metastatic
RecruitingInvestigationalNo placebo
Study of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment
InvestigationalNo placebo
- Disease:Gastrointestinal cancer metastatic
- Substances:Sunitinib[4-(METHYL-1H-PYRAZOL-4-YL)-BENZYL]-(6[7-(3-PYRROLIDIN-1-YL-PROPOXY)-IMIDAZO[1,2-A]PYRIDIN-3-YL]-PYRIMIDIN-4-YL]-AMINE
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Sunitinib
